Aequus Pharmaceuticals Inc.
AQSZF
$0.003
-$0.0009-23.08%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -77.29% | 40.61% | 446.48% | -30.17% | -85.95% |
| Total Receivables | -6.40% | 981.48% | 1,807.14% | -89.52% | -74.23% |
| Inventory | -46.07% | 386.42% | 12.16% | 35.21% | 43.78% |
| Prepaid Expenses | -5.51% | 10.58% | 52.50% | -67.31% | 13.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | -3.24% | 0.00% | 2.72% | -- |
| Total Current Assets | -36.98% | 148.00% | 127.37% | -50.54% | -61.44% |
|
|
|||||
| Total Current Assets | -36.98% | 148.00% | 127.37% | -50.54% | -61.44% |
| Net Property, Plant & Equipment | -19.35% | -21.39% | -18.18% | -15.46% | -15.65% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -26.68% | 10.34% | 13.38% | -34.19% | -55.50% |
|
|
|||||
| Total Accounts Payable | -8.95% | 41.07% | 144.10% | 217.43% | 331.45% |
| Total Accrued Expenses | -49.61% | -23.59% | -64.70% | -78.43% | 102.18% |
| Short-term Debt | 76.12% | 106.72% | 138.15% | 123.93% | 71.02% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 15.04% | 13.81% | 20.52% | 26.56% | -30.60% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 59.08% | 94.20% | 127.00% | 106.74% | 78.42% |
|
|
|||||
| Total Current Liabilities | 59.08% | 94.20% | 127.00% | 106.74% | 78.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 76.12% | 106.72% | 138.15% | 123.93% | 71.02% |
| Capital Leases | -19.66% | -21.00% | -17.12% | -13.79% | -4.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 48.95% | 74.17% | 95.80% | 79.51% | 59.05% |
|
|
|||||
| Common Stock & APIC | 0.13% | -3.25% | -0.08% | 2.48% | 1.49% |
| Retained Earnings | -8.51% | -5.65% | -9.37% | -12.71% | -13.06% |
| Treasury Stock & Other | 1.10% | -2.25% | 1.16% | 3.69% | 2.58% |
| Total Common Equity | -73.65% | -94.38% | -133.24% | -218.86% | -900.57% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -73.65% | -94.38% | -133.24% | -218.86% | -900.57% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -73.65% | -94.38% | -133.24% | -218.86% | -900.57% |
|
|
|||||
